Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation.

MLA

Fischer, A., et al. “Anti-B-Cell Monoclonal Antibodies in the Treatment of Severe B-Cell Lymphoproliferative Syndrome Following Bone Marrow and Organ Transplantation.” The New England Journal of Medicine, vol. 324, no. 21, May 1991, pp. 1451–56. EBSCOhost, https://doi.org/10.1056/NEJM199105233242102.

APA

Fischer, A., Blanche, S., Le Bidois, J., Bordigoni, P., Garnier, J. L., Niaudet, P., Morinet, F., Le Deist, F., Fischer, A. M., Griscelli, C., & et. al. (1991). Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. The New England Journal of Medicine, 324(21), 1451–1456. https://doi.org/10.1056/NEJM199105233242102

Chicago

Fischer, A, S Blanche, J Le Bidois, P Bordigoni, J L Garnier, P Niaudet, F Morinet, et al. 1991. “Anti-B-Cell Monoclonal Antibodies in the Treatment of Severe B-Cell Lymphoproliferative Syndrome Following Bone Marrow and Organ Transplantation.” The New England Journal of Medicine 324 (21): 1451–56. doi:10.1056/NEJM199105233242102.